Oncology Decoded
Oncology Decoded
CancerNetwork® is excited to announce the launch of Oncology Decoded, a new podcast that will discuss scientific data and practical application in the world of oncology. Hosted by 2 leading experts in the field, Benjamin Garmezy, MD, and Manoj Bupathi, MD, MS, this podcast will cover cutting-edge topics and offer actionable insights to help improve patient outcomes.
Autor
Oncology Decoded
Categoría
Web del podcast
Último episodio
25 de jun. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma 07.03.2025 25:30
This episode of Oncology Decoded tackled the challenging landscape of non-clear cell renal cell carcinoma (nccRCC), a heterogeneous group of tumors representing about 20% to 25% of all kidney cancers. The episode provided expert insights into the diagnosis and management of this complex disease. Meet the panel discussants: Manojkumar Bupathi, MD, MS, executive co-chair of Genitourinary Cancer Re...
2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer 05.03.2025 26:21
When treating hormone-sensitive prostate cancer (mHSPC), one question can be, when is the right time to optimize or intensify therapy? In the latest Oncology Decoded podcast, genitourinary oncologists discuss the use of radiotherapy and define oligometastatic disease including preferred treatment options. The discussion took place during the 2025 ASCO Genitourinary Cancers Symposium. The expert p...
1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer 04.03.2025 33:13
During the 2025 ASCO Genitourinary Cancers Symposium, Oncology Decoded held their inaugural podcast with a live filming taking place at the conference. The first episode focused on bladder cancer specifically, neoadjuvant vs adjuvant therapy options and the use of cisplatin vs carboplatin. Meet the expert panel involved in the discussion: Manojkumar Bupathi, MD, MS, executive co-chair of Geni...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos